Table 1 Patients’ clinicopathological parameters
Clinicopathological parameters | Distal subtotal gastrectomy (n = 144), n (%) | Total gastrectomy (n = 195), n (%) | P value |
|---|---|---|---|
Gender | Â | Â | 0.641 |
 Male | 94 (65) | 132 (68) |  |
 Female | 50 (35) | 63 (32) |  |
Age | Â | Â | 0.354 |
  ≤ 60 | 87 (60) | 108 (55) |  |
  > 60 | 57 (40) | 87 (45) |  |
Body mass index | Â | Â | 0.797 |
  < 19 | 19 (14) | 27 (14) |  |
  ~ <25 | 84 (60) | 111 (58) |  |
  ~ <30 | 31 (22) | 48 (25) |  |
  ≥ 30 | 5 (4) | 4 (2) |  |
Neoadjuvant chemotherapy | Â | Â | <0.001 |
 No | 117 (81) | 123 (63) |  |
 Yes | 27 (19) | 72 (37) |  |
Differentiation | Â | Â | 0.117 |
 Well | 16 (11) | 21 (11) |  |
 Moderate | 63 (44) | 67 (34) |  |
 Poor | 65 (45) | 107 (55) |  |
Lymphovascular invasion | Â | Â | 0.015 |
 No | 89 (63) | 96 (50) |  |
 Yes | 52 (37) | 97 (50) |  |
Tumor size | Â | Â | <0.001 |
  ≤ 5 cm | 109 (78) | 92 (47) |  |
  > 5 cm | 31 (22) | 102 (53) |  |
Location | Â | Â | 0.038 |
 Middle | 88 (61) | 140 (72) |  |
 Middle-lower | 56 (39) | 55 (28) |  |
Multi-tumor | Â | Â | 0.699 |
 No | 139 (98) | 192 (99) |  |
 Yes | 3 (2) | 3 (1) |  |
Adjuvant chemotherapy | Â | Â | <0.001 |
 Yes | 107 (74) | 186 (95) |  |
 No | 37 (26) | 9 (5) |  |
T stage | Â | Â | <0.001 |
 T1 | 37 (26) | 12 (6) |  |
 T2 | 19 (14) | 11 (6) |  |
 T3 | 3 (2) | 10 (5) |  |
 T4 | 82 (58) | 182 (83) |  |
N stage | Â | Â | 0.027 |
 N0 | 50 (39) | 52 (27) |  |
 N1 | 26 (20) | 30 (16) |  |
 N2 | 19 (15) | 32 (17) |  |
 N3 | 33 (26) | 77 (40) |  |